Clinical Trial Update: IVW-1001 Phase 1/2 in Subjects With Dry Eye Disease [Phase 1, Phase 2]

View source ↗

Summary

IVIEW Therapeutics reports completion of the Phase 1/2 trial of IVW-1001 for dry eye disease with results posted on 2026-02-12.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Dry Eye Disease

Drugs mentioned

• IVW-1001 (IVW-1001)

Snippet

Sponsor: IVIEW Therapeutics Inc. | Conditions: Dry Eye Disease | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2026-02-12